PI
The startup develops a testing device that utilizes spectroscopic technology to verify the identity and concentration of pharmaceuticals in real-time. This capability enhances drug diversion prevention and IV compounding verification, enabling healthcare providers to reduce costs and improve patient safety.
Updated 3 months ago
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a testing device that utilizes spectroscopic technology to verify the identity and concentration of pharmaceuticals in real-time. This capability enhances drug diversion prevention and IV compounding verification, enabling healthcare providers to reduce costs and improve patient safety.